The forecast for government expenditures on R&D in health in Germany shows a steady increase from 2024 to 2028, starting at 4.33 billion USD PPP and reaching 4.72 billion USD PPP. This indicates an average annual growth rate (CAGR) of approximately 2.17% over the five-year period from 2024 to 2028. While specific year-on-year variations are not listed, the overall trend is positive and indicative of a growing financial commitment to health R&D. As of 2023, the actual expenditure was lower, establishing a baseline for the forecast increases.
Future trends to watch for include potential impacts of economic conditions, policy changes, and technological advancements on the allocation and efficiency of R&D spending. Additionally, the emergence of new health challenges and innovations could further influence funding levels.
